NOTCH3 and CADASIL: In this regard, it was recently shown that a mutation in NOTCH3 causes cerebral autosomal‐dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and NOTCH3 selective agonists were suggested to be potentially effective in treating the disease.33